Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer’s Disease

Journal of Alzheimer s Disease(2023)10.3233/jad-221118Source: DataRank Database

Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer’s Disease is a research paper published in Journal of Alzheimer s Disease (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: bronzeTopics (74)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Oliver Langford ORCID,Natalie Levin,Rema Raman ORCID,Kevin E. Yarasheski ORCID,Tim West ORCID

Live enrichment

PubMed:23304386

National Institutes of Health

Grant: 5R01AG051848-02

A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimer's Disease Clinical Trials

National Institutes of Health

Grant: 1R01AG073979-01

Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome

National Institutes of Health

Grant: 1R01AG058252-01

A Blood Test for Screening Into Alzheimer's Prevention Trials

bronzeLicense: CC BY NC

publisherhttps://content.iospress.com:443/download/journal-of-alzheimers-disease/jad221118?id=journal-of-alzheimers-disease%2Fjad221118

publisherhttps://content.iospress.com/download?id=10.3233/JAD-221118

repositoryhttps://escholarship.org/content/qt2s26172c/qt2s26172c.pdf?t=sg53i3

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11191492/pdf/jad-92-jad221118.pdf

https://doi.org/10.3233/jad-221118

Fields of Study

0301 basic medicine0302 clinical medicine03 medical and health sciences

Keywords

Prevention (rcdc)AgingAmyloidogenic Proteins (mesh)Amyloid (mesh)NeurodegenerativeAcquired Cognitive Impairment (rcdc)Alzheimer's DiseasePeptide Fragments (mesh)Aging (rcdc)Biomedical Imaging (rcdc)Clinical Research (rcdc)Brain Disorders (rcdc)Amyloid beta-Peptides (mesh)1103 Clinical Sciences (for)Dementia (rcdc)A4Neurology & Neurosurgery (science-metrix)32 Biomedical and Clinical Sciences (for-2020)Neurosciences (rcdc)Neurodegenerative (rcdc)mass spectrometryAlzheimer Disease (mesh)Humans (mesh)Alzheimer's Disease (rcdc)clinical trial3209 Neurosciences (for-2020)amyloid-betaBiomarkers (mesh)4.2 Evaluation of markers and technologies (hrcs-rac)NeurologicalBiomedical ImagingCognitive SciencesAlzheimer’s disease4.2 Evaluation of markers and technologiesResearch ArticleAmyloidClinical SciencesClinical Trials and Supportive ActivitiesClinical Trials and Supportive Activities (rcdc)Positron-Emission Tomography (mesh)610Amyloidogenic Proteinsamyloid-βCross-Sectional Studies (mesh)Clinical ResearchAlzheimer Disease616Acquired Cognitive ImpairmentHumans3202 Clinical Sciences (for-2020)Neurology & NeurosurgeryAmyloid beta-PeptidesBiomedical and Clinical SciencesNeurological (hrcs-hc)Prevention4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)NeurosciencesAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)biomarkers1109 Neurosciences (for)Peptide FragmentsBrain Disorders4.1 Discovery and preclinical testing of markers and technologiesPETCross-Sectional Studies5202 Biological psychology (for-2020)Positron-Emission Tomography1702 Cognitive Sciences (for)Biological psychologyDementiaAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) (rcdc)